The cost-effectiveness of three strategies for the surgical treatment of symptomatic primary hyperparathyroidism

Annals of Surgical Oncology

Volumn 15, Issue 10, 2008, Pages 2653-2660

  Baliski, Chris ^a   Nosyk, Bohdan ^b   Melck, Adrienne ^a   Bugis, Samuel ^a   Rosenberg, Frances ^b   H Anis, Aslam ^b,c  

^a CENTRE FOR HEALTH EVALUATION AND OUTCOME SCIENCES   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Bilateral neck exploration; Cost effectiveness; Minimally invasive parathyroidectomy; Primary hyperparathyroidism; Unilateral neck exploration

Indexed keywords

ADULT; ARTICLE; BILATERAL NECK EXPLORATION; CLINICAL EVALUATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; HYPOCALCEMIA; MAJOR CLINICAL STUDY; PARATHYROIDECTOMY; PARESTHESIA; POSTOPERATIVE COMPLICATION; PRIMARY HYPERPARATHYROIDISM; SENSITIVITY ANALYSIS; SURGICAL TECHNIQUE; UNILATERAL NECK EXPLORATION;

COHORT STUDIES; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; MODELS, ECONOMIC; PARATHYROIDECTOMY; POSTOPERATIVE COMPLICATIONS; SENSITIVITY AND SPECIFICITY;

EID: 51649096334     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0066-0     Document Type: Article

References (26)

1. P Uden A Chan QY Duh 1992 Primary hyperparathyroidism in younger and older patients: symptoms and outcome of surgery World J Surg 16 791 7
2. A Bergenfelz P Lindblom S Tibblin 2002 Unilateral versus bilateral neck exploration for primary hyperparathyroidism Ann Surg 236 543 51
3. JI Merlino K Ko A Minotti 2003 The false negative technetium-99m- sestamibi scan in patients with primary hyperparathyroidism: correlation with clinical factors and operative findings Am Surg 69 225 30
4. S Sidhu AK Neill MB Russell 2003 Long-term outcome of unilateral parathyroid exploration for primary hyperparathyroidism due to presumed solitary adenoma WJS 27 339 42
5. CR Baliski JK Stewart DW Anderson 2005 Selective unilateral parathyroid exploration: an effective treatment for primary hyperparathyroidism Am J Surg 189 596 600
6. R Udelsman 2002 Six hundred fifty-six consecutive explorations for primary hyperparathyroidism Ann Surg 5 665 72
7. PG Gauger G Agarwal BG England 2001 Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: a 2-institution experience Surgery 130 1005 10
8. GL Irvin DM Carneiro CC Solorzano 2004 Progress in the operative management of sporadic hyperparathyroidism over 34 years Ann Surg 239 704 11
9. MJ Worsey SE Carty CG Watson 1993 Success of unilateral neck exploration for primary hyperparathyroidism Surgery 114 1024 30
10. H Chen LJ Sokoll R Udelsman 1999 Outpatient minimally invasive parathyroidectomy: A combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay Surgery 126 1016 22
11. TN Taylor EA Chrischilles 1997 Economic evaluation of interventions in endocrinology Endocrinol Metab Clin North Am 26 67 87
12. ED Dillavou JS Jenoff CM Intenzo 2000 The utility of sestamibi scanning in the operative management of patients with primary hyperparathyroidism J Am Coll Surg 190 526 31
13. SP Bugis CR Baliski 2003 Unilateral exploration for primary hyperparathyroidism in the era of sestamibi scans CJS 46 9
14. J Allendorf L Kim J Chabot 2003 The impact of sestamibi scanning on the outcome of parathyroid surgery J Clin Endo Metab 88 3015 8
15. SR Schell NE Dudley 2002 Clinical outcomes and fiscal consequences of bilateral neck exploration for primary idiopathic hyperparathyroidism without radionuclide imaging or minimally invasive techniques Surgery 133 32 9
16. AK Greene P Mowschenson RA Hodin 1999 Is sestamibi-guided parathyroidectomy really cost-effective? Surgery 126 1036 41
17. DW Denham J Norman 1998 Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon's choice of operative procedure J Am Coll Surg 186 293 304
18. Statistics Canada. Health Services CPI, Table No. 3260001, Series No. V735518
19. AH Anis HS Sun S Singh 2006 A cost-utility analysis of losartan versus atenolol in the treatment of hypertension with left ventricular hypertrophy Pharmacoeconomics 24 387 400
20. Drummond MF, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, 1987
21. British Columbia Medical Association. BCMA Guide to Fees, 2003
22. Government of British Columbia. Pharmacare Low Cost Alternative Reference Drug Program Booklet, Version 1.1, January 15, 2003
23. K Sejean S Calmus I Durand-Zaleski 2005 Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis Eur J Endocrinol 153 915 27
24. AH Briggs 2004 Statistical approaches to handling uncertainty in health economic evaluation Eur J Gastroenterol Hepatol 16 551 61
25. A Giordano D Rubello D Casara 2001 New trends in parathyroid scintigraphy Eur J Nucl Med 28 1409 20
26. A Gafni S Birch 2006 Incremental cost-effectiveness ratios (ICERs): the silence of the lambda Soc Sci Med 62 2091 2100